Substance Use Disorder: NCP, Stages, and Clinical Frameworks

Key Takeaways

• The DSM-5 classifies substance use disorder (SUD) as mild (2-3 criteria), moderate (4-5 criteria), or severe (6 or more criteria) based on 11 diagnostic criteria
• Clinical staging models describe addiction progression from experimentation through dependence, with “Stage 4” typically representing compulsive use despite serious consequences
• Nursing care plans (NCPs) for SUD address diagnoses including risk for injury, ineffective coping, and disturbed thought processes
• Expected clinical findings in SUD assessment include vital sign changes, behavioral indicators, cognitive impairment, and substance-specific physical signs
• These clinical frameworks directly influence treatment placement through the ASAM Criteria and insurance authorization

Substance Use Disorder (SUD): A medical condition defined by the DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition) as a cluster of cognitive, behavioral, and physiological symptoms indicating that an individual continues using a substance despite significant substance-related problems. SUD replaced the previous separate diagnoses of “substance abuse” and “substance dependence.”

Clinical frameworks for substance use disorder provide the structured language that healthcare providers, insurers, and treatment programs use to assess severity, plan treatment, and measure outcomes. Whether a nursing student studying care plans or a family member trying to understand a diagnosis, these frameworks explain how addiction is categorized, staged, and addressed within the medical system.

Substance Use Disorder Classification

Mild, Moderate, and Severe SUD

The DSM-5, published by the American Psychiatric Association (APA), defines substance use disorder using 11 diagnostic criteria. The number of criteria a person meets determines the severity classification:

Mild SUD: Meeting 2 to 3 of the 11 DSM-5 criteria. Individuals with mild SUD may have difficulty controlling use and may spend significant time obtaining or recovering from substance use, but major life disruptions may be limited.

Moderate SUD: Meeting 4 to 5 of the 11 DSM-5 criteria. Moderate SUD reflects a more entrenched pattern with clearer functional impairment across social, occupational, and health domains.

Severe SUD: Meeting 6 or more of the 11 DSM-5 criteria. Severe SUD typically involves physiological dependence (tolerance and withdrawal), continued use despite serious medical or psychiatric consequences, and significant impairment in daily functioning.

DSM-5 Criteria Count

The 11 DSM-5 criteria for substance use disorder are:

1. Taking the substance in larger amounts or for longer than intended
2. Wanting to cut down or stop but being unable to
3. Spending a great deal of time obtaining, using, or recovering from the substance
4. Experiencing cravings or strong urges to use
5. Failing to fulfill major obligations at work, school, or home due to use
6. Continuing use despite persistent social or interpersonal problems caused by substance effects
7. Giving up or reducing important social, occupational, or recreational activities because of use
8. Using the substance repeatedly in physically hazardous situations
9. Continuing use despite knowing it causes or worsens a physical or psychological problem
10. Developing tolerance (needing more to achieve the same effect, or diminished effect with the same amount)
11. Experiencing withdrawal symptoms when the substance is reduced or stopped

Tolerance: A physiological adaptation in which the body requires increasing amounts of a substance to achieve the same effect, or experiences diminished effect with continued use of the same amount. Tolerance is one of the hallmark indicators of physiological dependence.

A clinician conducts a structured interview to determine how many criteria are present, applies the severity classification, and uses this information alongside other assessment tools to recommend a treatment approach.

Stages of Addiction in Clinical Frameworks

Experimentation Through Dependence

Several clinical staging models describe addiction as a progressive process. While the specific terminology varies between models, the general progression follows a recognizable pattern:

Stage 1 — Experimentation: Initial, voluntary use of a substance, often in social settings. No pattern of regular use has developed, and the individual can stop without difficulty. Not all people who experiment with substances progress to further stages.

Stage 2 — Regular Use: Use becomes a pattern — perhaps every weekend, or in response to specific emotional triggers. The individual begins to develop a relationship with the substance as a coping mechanism or recreational habit. Early signs of tolerance may emerge.

Stage 3 — Risky Use / Problem Use: Use begins to cause identifiable problems — missed work, relationship conflict, legal issues, health effects. The individual may recognize the problem but continues using. This stage often meets criteria for mild to moderate SUD under the DSM-5.

Stage 4 — Dependence / Addiction: Compulsive use despite serious consequences. Physiological dependence (tolerance and withdrawal) is typically present. The individual’s life increasingly revolves around obtaining and using the substance. This stage generally corresponds to severe SUD under the DSM-5.

What Is Stage 4 of Addiction

Stage 4 in most clinical staging models represents the most severe form of substance use disorder. At this stage:

• The individual experiences physical dependence, with withdrawal symptoms when use is stopped
• Use continues despite severe health consequences, job loss, broken relationships, or legal problems
• The individual has lost the ability to reliably control when, how much, or how often they use
• Neurobiological changes in the brain’s reward, motivation, and decision-making circuits have become entrenched

Neuroadaptation: Changes in the brain’s structure and function that occur with repeated substance exposure, including alterations in dopamine signaling, prefrontal cortex activity, and stress response systems. These changes underlie the compulsive nature of addiction and are the basis for classifying SUD as a chronic brain disorder.

It is important to note that staging models are descriptive tools — not every individual follows a linear progression, and recovery is possible at any stage. NIDA emphasizes that addiction is a treatable, chronic medical condition, and that evidence-based treatments including medication-assisted treatment (MAT), behavioral therapy, and peer support produce meaningful outcomes.

Nursing Care Plans for Substance Use Disorder

Assessment and Expected Findings

Nursing Care Plan (NCP): A structured document used by nurses to guide patient care, consisting of a nursing assessment, nursing diagnoses, expected outcomes, planned interventions, and evaluation criteria. NCPs for SUD patients address both the acute effects of substance use and the underlying disorder.

When assessing a patient with substance use disorder, nurses should expect to find a combination of physical, psychological, and behavioral indicators. Expected findings vary by substance but commonly include:

Vital sign changes:

• Elevated heart rate and blood pressure (stimulant use, alcohol withdrawal)
• Depressed respiratory rate (opioid intoxication)
• Elevated temperature (alcohol withdrawal, stimulant use)
• Diaphoresis (withdrawal from multiple substance classes)

Behavioral indicators:

• Agitation or restlessness
• Slurred speech or impaired coordination
• Constricted or dilated pupils (substance-specific)
• Poor hygiene and nutritional deficits
• Track marks, nasal irritation, or other physical evidence of route of administration

Cognitive and psychological findings:

• Impaired judgment and decision-making
• Anxiety, depression, or mood lability
• Disorientation or confusion (severe intoxication or withdrawal)
• Denial or minimization of substance use
• Expressed hopelessness or suicidal ideation

Common Nursing Diagnoses

The North American Nursing Diagnosis Association International (NANDA-I) provides standardized nursing diagnoses applicable to SUD patients:

Risk for Injury: Related to impaired coordination, altered sensorium, withdrawal seizure potential, and poor judgment during intoxication or withdrawal. This is often the primary acute-phase diagnosis.

Ineffective Coping: Related to the use of substances as a primary coping mechanism for stress, emotional pain, or environmental stressors. Nursing interventions focus on identifying triggers and developing alternative coping strategies.

Imbalanced Nutrition: Less Than Body Requirements: Related to the prioritization of substance use over eating, malabsorption associated with chronic alcohol use, or stimulant-related appetite suppression.

Disturbed Thought Processes: Related to substance-induced cognitive impairment, withdrawal delirium, or co-occurring psychiatric conditions. Interventions include reality orientation, safety monitoring, and medication management.

Risk for Self-Directed Violence: Related to depression, hopelessness, impulsivity during intoxication, or psychiatric comorbidity. Suicide risk assessment is a critical component of SUD nursing care.

How Clinical Frameworks Guide Treatment

ASAM Criteria Integration

The severity classification from the DSM-5 directly feeds into the ASAM Criteria assessment process. When a clinician determines that a patient has severe SUD (6 or more criteria), this informs the Dimension 1 and Dimension 5 assessments within the ASAM framework, often supporting placement at a higher level of care.

Clinical Assessment: The comprehensive evaluation process that integrates DSM-5 diagnosis, ASAM dimensional assessment, physical examination, psychosocial history, and patient preference to develop an individualized treatment recommendation. No single tool determines treatment placement; the assessment synthesizes multiple data sources.

The relationship between frameworks works as follows:

• DSM-5 answers the question: does this person have a substance use disorder, and how severe is it?
• ASAM Criteria answers the question: given the severity and all related clinical factors, what level of care is appropriate?
• Nursing care plans answer the question: given the patient’s current presentation and diagnoses, what nursing interventions will address immediate and ongoing needs?

Matching Severity to Level of Care

As a general principle, more severe substance use disorders require more intensive treatment settings. However, the relationship is not rigid:

• A patient with severe opioid use disorder but stable housing, strong social support, and a commitment to MAT may do well in outpatient treatment (ASAM Level 1)
• A patient with moderate alcohol use disorder but unstable housing and co-occurring severe depression may need residential treatment (ASAM Level 3.5)

The clinical frameworks exist to prevent both overtreatment (placing someone in residential when outpatient would suffice) and undertreatment (sending someone to outpatient who needs the structure and medical oversight of inpatient care).

---

This glossary entry is part of our Addiction Treatment Glossary. For a detailed breakdown of treatment levels, see What Is the ASAM Criteria?. For related content on psychiatric assessment in the addiction context, read What Is a Psychiatric Hold?. To explore how SUD diagnosis relates to the broader understanding of addiction, visit our guides on substance use disorder vs. addiction and stages of addiction.